IL111184A - Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin - Google Patents

Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin

Info

Publication number
IL111184A
IL111184A IL11118494A IL11118494A IL111184A IL 111184 A IL111184 A IL 111184A IL 11118494 A IL11118494 A IL 11118494A IL 11118494 A IL11118494 A IL 11118494A IL 111184 A IL111184 A IL 111184A
Authority
IL
Israel
Prior art keywords
diclofenac
cyclodextrin
inclusion complex
unsubstituted beta
crystalline inclusion
Prior art date
Application number
IL11118494A
Other languages
English (en)
Other versions
IL111184A0 (en
Original Assignee
Farmarc Nederland B V Of Cito
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmarc Nederland B V Of Cito filed Critical Farmarc Nederland B V Of Cito
Publication of IL111184A0 publication Critical patent/IL111184A0/xx
Publication of IL111184A publication Critical patent/IL111184A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL11118494A 1993-10-08 1994-10-06 Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin IL111184A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA937480 1993-10-08

Publications (2)

Publication Number Publication Date
IL111184A0 IL111184A0 (en) 1994-12-29
IL111184A true IL111184A (en) 2000-08-13

Family

ID=66767030

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11118494A IL111184A (en) 1993-10-08 1994-10-06 Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin

Country Status (12)

Country Link
US (1) US5674854A (de)
EP (1) EP0647451B1 (de)
JP (1) JPH07196484A (de)
KR (1) KR950010910A (de)
CN (1) CN1161115C (de)
AT (1) ATE294593T1 (de)
AU (1) AU682887B2 (de)
CA (1) CA2133885C (de)
DE (1) DE69434356T2 (de)
ES (1) ES2240960T3 (de)
IL (1) IL111184A (de)
ZA (1) ZA948078B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735136B1 (fr) * 1995-06-08 1997-08-14 Roquette Freres Composition pulverulente d'hydroxypropyl-betacyclodextrine et son procede de preparation.
HUP9600758A2 (en) * 1996-03-27 1998-03-02 Cyclolab Ciklodextrin Kutato F Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption
US6984632B1 (en) * 1999-07-01 2006-01-10 Italfarmaco S.P.A. Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives
US7122376B2 (en) * 2001-11-01 2006-10-17 Facet Analytical Services And Technology, Llc Calibration standards, methods, and kits for water determination
US7049146B2 (en) 2000-11-14 2006-05-23 Facet Analytical Services And Technology, Llc Calibration standards, methods, and kits for water determination
JP2005298338A (ja) * 2002-02-27 2005-10-27 Eisai Co Ltd 速崩壊性圧縮成形製剤
KR100473716B1 (ko) * 2002-03-27 2005-03-08 주식회사 참 존 7-디하이드로콜레스테롤 및 사이클로덱스트린의 포접복합체, 이를 포함하는 화장료 조성물 및7-디하이드로콜레스테롤의 안정화방법
AU2003270727A1 (en) * 2002-09-17 2004-04-08 Luna Innovations, Inc. Remote temperature sensing of small volume and related apparatus thereof
FR2850040B1 (fr) * 2003-01-20 2005-03-11 Centre Nat Rech Scient Systemes pour microencapsulation et leurs applications
DE602004025151D1 (de) * 2004-03-10 2010-03-04 Shimoda Biotech Pty Ltd Stabile injizierbare Diclofenac- Zubereitungen
BRPI0510119A (pt) 2004-04-23 2007-09-25 Cydex Inc formulação para dpi contendo sulfoaquil éter de ciclodextrina
SI2952197T1 (sl) 2005-10-26 2017-09-29 Cydex Pharmaceuticals, Inc. Sestavki sulfoalkil eter ciklodekstrina in metode priprave le-tega
US20070267033A1 (en) * 2006-02-09 2007-11-22 Philip Morris Usa Inc. Gamma cyclodextrin flavoring-release additives
MX2008012496A (es) * 2006-03-28 2009-01-07 Javelin Pharmaceuticals Inc Formulaciones de farmacos anti-inflamatorios no esteroidales de baja dosis y beta-ciclodextrina.
EP2522343A1 (de) * 2006-03-28 2012-11-14 Javelin Pharmaceuticals, Inc. Formulierungen aus niedrigdosiertem Diclofenac und Beta-Cyclodextrin
FR2912061A1 (fr) * 2007-02-01 2008-08-08 Aliscience Soc Par Actions Sim Complexes d'inclusion de cysteine, leur presparation et les compositions les contenant
MY166036A (en) 2011-07-20 2018-05-21 Hospira Inc Methods of treating pain
EP4653002A3 (de) 2020-03-23 2026-02-25 Czap Research And Development, LLC Orale terpencyclodextrin-einschlusskomplexvehikel
GB202105833D0 (en) * 2021-04-23 2021-06-09 Nacamed As Silicon particles for drug delivery

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5984821A (ja) * 1982-11-04 1984-05-16 Teikoku Chem Ind Corp Ltd 徐溶化組成物
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
US4845188A (en) * 1988-08-19 1989-07-04 Eastman Kodak Company Condensation polymers containing methine ultraviolet radiation-absorbing residues and shaped articles produced therefrom
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
IT1241088B (it) * 1990-03-27 1993-12-29 Chiesi Farma Spa Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
EP1004318A3 (de) * 1991-06-21 2002-08-07 Takeda Chemical Industries, Ltd. Zyklodextrin-zusammensetzung
DE4200792A1 (de) * 1992-01-15 1993-07-22 Solvay Fluor & Derivate Aufarbeitung der fluorwasserstoff-phase aus reaktionsgemischen
JPH0616547A (ja) * 1992-07-01 1994-01-25 Wakamoto Pharmaceut Co Ltd 消炎点眼剤

Also Published As

Publication number Publication date
ATE294593T1 (de) 2005-05-15
AU682887B2 (en) 1997-10-23
DE69434356D1 (de) 2005-06-09
AU7448694A (en) 1995-04-27
CA2133885A1 (en) 1995-04-09
US5674854A (en) 1997-10-07
JPH07196484A (ja) 1995-08-01
DE69434356T2 (de) 2006-05-04
KR950010910A (ko) 1995-05-15
EP0647451B1 (de) 2005-05-04
ES2240960T3 (es) 2005-10-16
CA2133885C (en) 2008-12-16
IL111184A0 (en) 1994-12-29
EP0647451A1 (de) 1995-04-12
CN1107042A (zh) 1995-08-23
CN1161115C (zh) 2004-08-11
ZA948078B (en) 1995-06-05

Similar Documents

Publication Publication Date Title
ZA948078B (en) Inclusion complex.
GB9309324D0 (en) Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
AU8979191A (en) 3,7-disubstituted indole derivatives
IL112074A0 (en) Branched-amino-substituted thiazoles, their preparation and pharmaceutical compositions containing them
TW248559B (de)
GR3033350T3 (en) Use of Beta-aminopropionic acid derivatives as fungicides
AU562423B2 (en) Benzoic acid derivatives
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives
AU563426B2 (en) 3-alkoxy-2(n-pyrrolidino)-n-pyridyl-n-furyl (or thienyl) methyl propylamines
AU2240388A (en) Azachromane derivatives
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
AU8452591A (en) 2-thio-1-aminocarbonyl cyclo alk-1-enes
DE69108580D1 (de) Optisch aktives Derivat der d-2-(6-Methoxy-2-naphthyl)-propionsäure und es enthaltende pharmazeutische Zusammensetzungen.
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
AU657684B2 (en) Improvements in or relating to organic compounds
WO1995022544A3 (de) Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika
AU6797590A (en) Improvements in or relating to organic compounds
RU1807052C (ru) 1,10-Фенантролинаты 4-нитрофенил-4 @ -пиридилметанидов натри или кали , обладающие индикаторными свойствами по отношению к воде или протонным органическим растворител м с интервалом перехода окраски от синей к бесцветной при рК @ 29
BG50219A1 (en) Cepheme derivatives containing a benzoxazolone cycle, and a method for their preparation
AU2089292A (en) Hydantoin derivatives
IT1276893B1 (it) 1,3,2-benzoossiazafosfolidine sostituite e procedimento per la loro preparazione
IT1276892B1 (it) 1,3,2-benzoossiazafosfolidine sostituite e procedimento per la loro preparazione

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees